.9% in 460 limbs treated with 810-nm EVLA and
observed sustained improvement using the VCSS. These
authors also found that outcomes were not affected by the
presence or absence of deep vein insufficiency.
Complications. In an international endovascular
working group registry that included 3696 procedures,
bruising after EVLA was observed in 75%, paresthesia in
3%, thrombophlebit